![These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018 These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aimovig-06.jpg&id=732122)
These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018
SAŽETAK KARAKTERISTIKA LEKA Ovaj lek je pod dodatnim praćenjem. Time se omogućava brzo otkrivanje novih bezbednosnih informac
![These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018 These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aimovig-01.jpg&id=732122)
These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018
![These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018 These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aimovig-62.jpg&id=732122)
These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018
Instructions for Use AIMOVIG® (AIM-oh-vig) (erenumab-aooe) Injection, For Subcutaneous Use Single-Dose Prefilled Syringe 70
![These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018 These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG® (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aimovig-03.jpg&id=732122)